Transient atrial fibrillation after subcutaneous apomorphine bolus

Movement Disorders

Volumn 11, Issue 5, 1996, Pages 584-585

  Stocchi, F ^a   De Pandis, M F ^b   Delfino, F A ^c   Anselmo, T ^c   Frongillo, D ^c  

^a Mediterranean Institute of Neuroscience   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CARBIDOPA; DOMPERIDONE; GLYCERYL TRINITRATE; LEVODOPA; TRIHEXYPHENIDYL; VERAPAMIL;

AGED; ASTHENIA; BRADYCARDIA; CASE REPORT; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HUMAN; HYPERSALIVATION; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; THORAX PAIN; VOMITING;

EID: 0029792150     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110520     Document Type: Short Survey

References (13)

1. Obeso JA, Grandas F, Vaamonde J. Apomorphine infusion for motor fluctuations in Parkinson's disease. Lancet 1987;i:1376-1377.
2. Braham J, Sarova Pinhas I, Goldhammer Y. Apomorphine in parkinsonian tremor. Br Med J 1970;2:768.
3. Hughes AJ, Lees AJ, Stern GM. Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet 1990;i:336:32-34.
4. Pollak P, Mallaret M, Gaio JM, Hommel M, Perret J. Blood pressure effects of apomorphine and domperidone in parkinsonism. In: Yahr MD, Bergmann KJ, eds. Parkinson's disease. New York: Raven, 1987:263-266. (Advances in neurology; vol 45).
5. Pollak P, Mallaret M, Gaio JM, Hommel M, Perret J. Blood pressure effects of apomorphine and domperidone in parkinsonism. In: Yahr MD, Bergmann KJ, eds. Parkinson's disease. New York: Raven, 1987:263-266. (Advances in neurology; vol 45).
6. Rascol OJ, Montastruc JL. Cardiovascular effects of apomorphine in humans: evidence of peripheral mechanism. Clin Neuropharmacol 1986;9:566-569.
7. Hunter KR, Hollman A, Laurence DR, Stern GM. Levodopa in parkinsonian patients with heart disease. Lancet 1971; 8:932-934.
8. Leibowitz M, Lieberman AN, Goldstein M. The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's disease. In: Fahn S, Calne DB, Shoulson I, eds. Experimental therapeutics of movement disorders. New York: Raven, 1983:121-130. (Advances in neurology; vol 37).
9. Leibowitz M, Lieberman AN, Goldstein M. The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's disease. In: Fahn S, Calne DB, Shoulson I, eds. Experimental therapeutics of movement disorders. New York: Raven, 1983:121-130. (Advances in neurology; vol 37).
10. Cannata D, Narbone NB. Clinical observations on the role of the vegetative nervous system in the pathogenesis of atrial fibrillation. Cardiologia 1958;32:329-345.
11. Brignole M, Gianfranchi L, Menozzi C, Raviele A. Role of autonomie reflexes in syncope associated with paroxysmal atrial fibrillation. J Am Coll Cardiol 1993;22:1123-1129.
12. Coumel P. Cardiac arrhythmias and the autonomie nervous system. J Cardiovasc Electrophysiol 1993;4:338-355.
13. Attanasio A, Capria A, Leggiadro G, et al. Transient cardiac arrest during continuous intravenous infusion of apomorphine. Lancet 1990;336:1321.